(MedPage Today) — A searchable database of quality improvement projects may prevent duplication of efforts, suggests Fred N. Pelzman, MD
Research and Markets: Proliferative Vitreoretinopathy (PVR) Pipeline Review, H2 2015 – 2 Companies & 7 Drug Profiles
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/jb2qxk/proliferative) has announced the addition of the “Proliferative Vitreoretinopathy (PVR) – Pipeline Review, H2 2015” report to their offering. This report p…
Ocular Therapeutix™ to Participate in Two Investor Conferences in September 2015
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph….
Misleading advertisement about Pentacam prohibited in European Union
The District Court in The Hague, Netherlands, ruled that i-Optics is to refrain from using “misleading and defamatory advertisements” in reference to the Pentacam in the European Union, according to a press release from Oculus.The order against i-Optics includes a notification to be posted on its website for 2 months. The note reads:
Ophthalmic Patients on Antithrombotic Drugs
What are the best ways to manage ophthalmic surgical patients on antithrombotic therapy? This article provides some guidance. The British Journal of Ophthalmology
Femtosecond laser-assisted cataract surgery may provide more stable refraction at 6 months
Femtosecond laser-assisted cataract surgery with IOL implantation may induce a lower variability of anterior chamber depth over time with more stable postoperative refraction compared with conventional cataract surgery, according to a study.The prospec…